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Abstract 
Since our previous publication of organ dose for the pediatric CT cohort in the United Kingdom, 
there have been questions about the magnitude of uncertainty in our dose estimates.  We 
therefore quantified shared and unshared uncertainties in empirical CT parameters extracted 
from 1,073 CT films (1978 – 2008) from 36 hospitals in the study and propagated these 
uncertainties into organ doses using Monte Carlo random sampling and NCICT organ dose 
calculator.  The average of 500 median brain and marrow doses for the full cohort was 35 (95% 
Confidence Interval: 30 - 40) mGy and 6 (5 – 7) mGy, respectively.  We estimated that shared 
uncertainty contributed about 99% of coefficient of variation of median brain doses in brain 
scans compared to shared uncertainty (1% contribution).  We found that the previous brain 
doses were slightly underestimated for <1990 and overestimated for >1990 compared to the 
results in the current study due to the revised CTDI models based on CT films. 
1 Introduction 
Computed Tomography (CT) is one of the crucial diagnostic tools in modern medicine.  However, 
exposure to ionizing radiation has been a concern especially for pediatric patients due to the 
higher radio-sensitivity and longer life expectancy in children1.  Several epidemiological studies 
have reported an increased incidence of different types of cancer in pediatric patients after CT 
scans2–5.  The retrospective cohort study of pediatric CT in the United Kingdom3, the first 
epidemiological study of CT risk based on organ dose estimates, reported a positive dose-
response relationship for brain tumors and leukemia based on the analysis of about 180,000 
children, adolescents, and adults younger than 22 years of age after CT scans conducted 
between 1985 and 2008. 
Retrospective organ dose estimation for a large-size patient cohort who underwent CT 
scans decades ago poses several challenges.  Obtaining access to archived CT films or image files 
may not be practical as films may have been destroyed, and even if available it may be 
impractical to retrieve them from a resource perspective.  Even when films are available, it is 
challenging to manually extract scan parameters from a large number of CT films for dosimetry.  
As an alternative, organ dose for retrospective cohorts can be estimated based on national 
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surveys of scanning parameters such as tube current, tube potential, Computed Tomography 
Dose Index (CTDI), and Dose-Length Product (DLP) that are provided from CT scanners6–9.  
Unfortunately, not many countries have performed national-scale surveys with a level of quality 
sufficient for retrospective organ dose reconstruction.  The most comprehensive national CT 
surveys to date are the ones conducted in the United Kingdom in 198910, 200311, and 201112.  
The surveys for 1989 and 2003 were the basis of organ dose reconstruction6 for the study of CT 
risk in the United Kingdom3. 
Since the publication of the organ dose database for the UK CT cohort6 based on 
nationwide surveys of hospital protocols, there have been questions about uncertainty in the 
dose estimates and its impact on risk analysis13,14.  In the current study, we identified and 
quantified the sources of uncertainty in CT parameters based on 1,073 CT films or Digital 
Imaging and Communications in Medicine (DICOM) files extracted from a subset of the hospitals 
participating in the UK CT cohort study.  Temporal trends in tube current and CTDI from this set 
of CT films were recently published15.  To quantify the magnitude of the uncertainties in our 
dose estimates we propagated uncertainties in different scan parameters into organ dose 
estimates by computing multiple realizations of plausible doses using a Monte Carlo sampling 
technique16–18 and an in-house organ dose calculation tool19.  Uncertainties included in some 
scan parameters are shared to varying degrees by subsets of the cohort, but other uncertainties 
are specific to each subject (i.e., unshared uncertainty).  We categorized the uncertainties as 
whether they were shared or unshared errors, to facilitate assessment of the potential impact of 
the uncertainties on the risk coefficients and their confidence intervals.  The updated organ 
doses were then compared with the previous cohort doses6 estimated from the two UK surveys. 
2 Materials and methods 
In the UK CT cohort study, five parameters are available for each cohort member: age, gender, 
scan year, hospital, and scan type (e.g., head, chest, abdomen).  Table 1 summarizes the number 
of scans for different scan types in the UK CT study.  For organ dose calculations in the current 
study, we adopted an algorithm that we previously published19.  The algorithm requires the 
following parameters dependent upon the patient and the CT scanner: age and gender, the CT 
slice locations of scan start and scan end, tube potential (kVp), CTDIvol and type of CTDI phantom 
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(16 or 32 cm) used for deriving CTDIvol.  We quantified uncertainties in these parameters except 
age and gender and incorporated them into organ dose in three steps.  First, we developed 
probability distributions and regression models for scan parameters using the CT parameters 
collected from the UK hospitals.  We separated uncertainties in different parameters into shared 
and unshared uncertainties.  Second, 500 realizations of scan parameters for each scan (e.g., 
three sets of scan parameters were used in case of three repeated scans) in the cohort were 
generated using a Monte Carlo random sampling approach16 that allows for the sampling of 
shared and unshared parameters.  Third, organ doses were calculated for each realization of 
each scan using an in-house CT organ dose calculator19. 
2.1 Modeling uncertainty in scan parameters 
2.1.1 Extraction of scan parameters from CT data 
We retrieved 1,073 CT films or DICOM file sets from 36 hospitals out of approximately 100 
hospitals that participated the UK CT cohort study.  The age of the CT patients ranged from 0 to 
19 years old at the time of CT scan, which were conducted between 1978 and 2008.  We 
manually extracted the manufacturer and model of CT scanners, tube current-time product 
(mAs) (averaged when tube current modulation used), and tube potential (kVp).  To extract scan 
start and end locations from CT images, we obtained whole body CT images of an adult male20 
with a slice interval of 1 cm, numbered the slices from the top of the head to the bottom of the 
feet (e.g., 1 to 172), and recorded the slice number of axial image visually matching patient 
images for each scan set.  For example, slice #1 to slice #24 were recorded for a head CT scan, 
meaning scan ranged 0 – 24 cm from the top of the head.  A summary of the CT film data was 
recently published15 but detailed evaluation of the scan location was not included in that 
analysis.  It was, however, used in the assessment of the uncertainties (see below) in the current 
study. 
2.1.2 Parameter probability distributions 
We developed probability distributions for the following four parameters: tube potential, pitch, 
scan location (scan start and scan length), and scan type.  First, we developed probability 
distributions by analyzing the association between tube potential values (<120, 120, 120 - 130, 
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130 - 140 kVp) and parameters available from the UK CT cohort (scan year, scan type, and 
patient age) using multinomial logistic regression models.  Second, since pitch values were not 
available from the CT films, either a fixed value of 1.0 was used or parameters for a triangular 
distribution were derived from the UK CT dose surveys10,11 depending on scan type.  A fixed 
pitch value of 1.0 was used for full head, extremity, partial head, and spine scans.  A triangular 
distribution spanning from 1.0 to 2.0 with mode of 1.5 was used for abdomen, pelvis, chest, and 
neck scans. 
Third, probability distributions for scan start location and scan length for each scan type 
were developed by combining the scan locations extracted from the UK CT data using the 
method described in Section 2.1.1 and approximate estimates provided by a practicing pediatric 
radiologist from the UK (KMcH).  The radiologist’s estimates were used as uniform prior 
distributions in conjunction with the empirical scan location data to estimate distributions of 
scan location.  Scan start location and scan length were assumed to be normally distributed but 
truncated based on judgement and radiologist’s estimates to prevent simulating highly unlikely 
or unrealistic values.  During simulation a scan start location and scan length were sampled from 
the truncated normal distribution for the scan type.  The scan start location and scan length 
were added together to derive the scan end location.  The scan start and end locations derived 
for an adult male height (172 cm) were then non-uniformly scaled down to the appropriate age 
using scan location scaling tables, which were developed based on the growth curve of different 
body parts (e.g., head/neck, torso, and legs) of the reference size computational phantoms21. 
Finally, we used the distribution of scan types (Table 1) for the cohort members of 
whom scan type is unknown (about 7%, 22,297 scans out of 317,992 scans performed for 
180,000 patients).  In the previous dosimetry6, we averaged organ doses from all scan types for 
these unknown scans.  In the current study, unknown body locations were simulated by a body 
location sampled from all possible scan types weighted by the relative number of scans (Table 
1).  A similar approach was used for CT scans defined generically as “spine” scans, without 
specific locations.  These cases were simulated by randomly selecting one of cervical spine, 
thoracic spine, or lumbar spine weighted by the relative number of scans (Table 1). 
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2.1.3 Regression model of CTDI 
A total of 794 scans out of 1,073 scans were identified from the UK CT data, where scanner 
manufacturer and model (represented by scanner-specific normalized CTDIw), tube potential 
(kVp), and current-time product were all available.  By combining these parameters, we 
calculated CTDIw (mGy) using the following equation: 
 
  𝐶𝑇𝐷𝐼𝑤(𝑚𝑎𝑘𝑒, 𝑚𝑜𝑑𝑒𝑙, 𝑘𝑉𝑝, 𝐶𝑇𝐷𝐼 𝑝ℎ𝑎𝑛𝑡𝑜𝑚) = 
  𝑛𝐶𝑇𝐷𝐼𝑤(𝑚𝑎𝑘𝑒, 𝑚𝑜𝑑𝑒𝑙, 𝑘𝑉𝑝, 𝐶𝑇𝐷𝐼 𝑝ℎ𝑎𝑛𝑡𝑜𝑚) × (
𝐼×𝑡
100
)  (1) 
 
where 𝑛𝐶𝑇𝐷𝐼𝑤(𝑚𝑎𝑘𝑒, 𝑚𝑜𝑑𝑒𝑙, 𝑘𝑉𝑝, 𝐶𝑇𝐷𝐼 𝑝ℎ𝑎𝑛𝑡𝑜𝑚) (mGy/100mAs) is the CTDIw normalized to 
100 mAs for a given scanner 𝑚𝑎𝑘𝑒 𝑎𝑛𝑑 𝑚𝑜𝑑𝑒𝑙, tube potential (kVp), and type of CTDI phantom 
(16 cm or 32 cm in diameter); 𝐼 × 𝑡 (mAs) is the product of the tube current (𝐼) and the single 
rotation time (𝑡).  The values of 𝑛𝐶𝑇𝐷𝐼𝑤, were obtained for each scan from the previously-
published library22 based on the scanner make, model, tube potential (kVp), and CTDI phantom 
type.  We then multiplied the 𝑛𝐶𝑇𝐷𝐼𝑤 by current-time product (mAs) to obtain 𝐶𝑇𝐷𝐼𝑤. 
We then derived a regression model for CTDIw at 120 kVp and scan parameters available 
from the UK CT cohort (patient age, scan year, scan type, and hospital).  To maximize the sample 
size, we scaled CTDIw at different tube potentials to 120 kVp based on the fact that weighted 
CTDI increases with tube potential to the power of 2.523.  In organ dose calculations later, we 
scaled CTDIw at 120 kVp sampled from the regression model back to original tube potentials.  
Based on the regression analysis reported in the previous paper15, we assumed that CTDIw 
before 1990 would be constant and start decreasing after 1990 exponentially.  Variation within 
hospitals, CT scan studies, and residual variations (variation that is otherwise unexplainable by 
the parameters in our CTDI model) were also incorporated into the CTDI regression model. 
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2.2 Monte Carlo sampling of parameters 
We used a Monte Carlo sampling method16 to generate “realizations” of plausible parameters 
for each scan.  Multiple realizations were generated for each scan while adhering to proper 
parameter sharing among cohort subgroups defined hierarchically by hospital, scan type, and CT 
study.  One “study” was defined as a scan date for one patient in a given hospital possibly being 
scanned several times, either over the same body region (e.g. chest CT scan before and after 
contrasting medium injection) or different body regions (e.g. scan of the chest and the 
abdomen), on a given day.  In those situations, scan parameters would be more likely to be 
similar than when scans occurred on different dates, possibly performed by different 
radiologists, or for different patients. 
By consulting practicing pediatric radiologists, we separated uncertainties involved in 
different CT parameters into their respective shared and unshared components.  The CTDI 
regression constant and coefficients were shared across realizations, but scan type coefficient 
was only shared by those with the same scan types across realizations.  Hospital and study 
variations in the CTDI regression model were shared across realizations, but residual variations 
in the CTDI model were sampled independently (unshared).  Tube potential (kVp) and pitch 
were shared by hospital and scan type, while scan start location and scan length were sampled 
independently (unshared).  Figure 1 shows the workflow in parameter sampling where shared 
and unshared uncertainties were propagated into dose in different ways.  A total of 500 
realizations for 317,992 scans were generated using the sampling scheme by using the NIH 
Biowulf computer cluster at the National Institutes of Health (http://hpc.nih.gov). 
2.3 Organ dose calculation 
We imported the 500 realizations of scan parameters into an in-house CT dose calculator, 
National Cancer Institute dosimetry system for Computed Tomography (NCICT)19.  NCICT is 
based on a comprehensive library of organ dose conversion coefficients derived from a series of 
reference computational human phantoms combined with Monte Carlo transport of X-ray from 
a reference CT scanner.  The program selects organ dose conversion coefficients based on 
patient age, gender, scan locations, and X-ray spectrum, and then converts scan-specific CTDIvol 
to organ dose.  NCICT provides dose to 33 organs and tissues including active marrow.  The 
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program can import text files of input parameters and automatically generate output files of 
organ doses19.  Over 5.2109 (317,992 scans  500 realizations  33 organs) organ doses were 
calculated using this process. 
To efficiently analyze the large number of organ doses, we derived probability 
distribution functions (PDFs)(different from the probability distributions we derived from tube 
potential described in Section 2.1.2) and then derived cumulative distribution functions (CDFs) 
from the full organ doses for major organs and scan types.  We then quantified dosimetric 
uncertainties related to shared and unshared uncertainties in two ways: dose range (min and 
max) across all dose realizations and coefficient of variation (COV) among median doses of each 
dose realization.  We expected that the higher dose uncertainty, the greater would be the dose 
range and COV. 
To understand the contribution of shared and unshared uncertainty to dose variation, 
we conducted a sensitivity analysis.  We first calculated 500 brain doses for the full cohort by 
using the 500 parameter realization sets after removing both shared and unshared 
uncertainties.  We then recalculated 500 brain doses after removing shared uncertainties while 
adding unshared uncertainties.  We compared dose range and COV from the two sets of doses 
with those from the data where both shared and unshared uncertainties were propagated.  We 
also validated that shared uncertainties were actually shared in the final cohort dose as 
intended through calculating Pearson correlation coefficients for the first 1,000 scans out of 
317,992 scans with 500 brain dose realizations.  We observed how the correlation coefficients 
changed as we grouped the 1,000 scans by two key shared parameters, scan type (𝜃) and 
hospital (ℎ𝑣).  We expected that correlation coefficients would increase as we group the scans 
sharing uncertainties. 
3 Results 
3.1 Probability distribution and regression models 
Based on the Akaike Information Criterion (AIC), we found that a model including scan year 
(<1995, 1995+) and scan type (head and body) had the best goodness of fit for tube potential.  
Head scans were limited to brain, partial brain, and facial bone scans; all other scans were 
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deemed body scans.  No further improvement in AIC was obtained when accounting for 
patient’s age at scan.  The probability distributions of tube potential (Figure 2) depict the high 
frequency of 120 kVp tube potential both before 1995 and 1995+ for head and body scans.  The 
second most frequent tube potential was 130 kVp.  A total of 20% (head) and 25% (body) of 
scans used 130 kVp before 1995.  The ratio slightly decreased to 18% (head) and 15% (body) for 
1995+.  Only 2% (head) and 3% (body) of scans used a tube potential smaller than 120 kVp 
1995+. 
From the CTDIw at 120 kVp derived from CT parameters, we developed the following 
regression model: 
 
 𝐶𝑇𝐷𝐼𝑤,120 = 𝑒
𝐵0+𝐵1(𝑎𝑔𝑒−10)+𝐵2(𝑠𝑦𝑟−2000)+𝜃(𝑠𝑐𝑎𝑛)+ℎ𝑣+𝑠𝑣+𝑟𝑣  (2) 
 
where 𝐶𝑇𝐷𝐼𝑤,120 is weighted CTDI at 120 kVp, 𝐵0 is intercept for head or body scan, 𝐵1 and 𝐵2 
are coefficients on 𝑎𝑔𝑒 and 𝑠𝑦𝑟 (scan year truncated at 1990) variables, respectively, and 𝜃 is 
scan indicator, a function of 𝑠𝑐𝑎𝑛 type.  The 𝐵0, 𝐵1, 𝐵2, and 𝜃 are tabulated in Table 2a.  The 
remaining three parameters model shared uncertainty within hospital (ℎ𝑣), CT scan study (𝑠𝑣), 
and residual random unshared variation (𝑟𝑣), of which distribution type, mean, and standard 
deviation (SD) are shown in Table 2b.  The normal deviates used to generate samples for these 
variables were constrained to the 98% confidence interval to remove unrealistic outliers.  The 
CTDIvol for (a) brain and (b) chest scan at different age group was calculated from the regression 
model (Figure 3). 
3.2 Dose realizations for full cohort 
Figure 4 shows the CDFs of the 500 dose realizations for (a) brain and (b) active marrow from 
brain scans and (c) lung and (d) thyroid from chest scans.  The mean of 500 median doses for 
brain and active marrow from brain scans are 35 (95% Confidence Interval: 30 - 40) mGy and 6 
(5 - 7) mGy, respectively.  For chest scans, the mean of 500 median doses for the lungs and 
thyroid are 12 (10 - 15) mGy and 7 (6 - 8) mGy, respectively.  COV for both brain and active 
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marrow doses in brain scans are 8.5%.  For lung and thyroid dose resulting from chest scans, 
COV are 10.8% and 10.9%, respectively. 
Figure 5 shows the impact of shared and unshared uncertainty on 500 brain doses in 
brain CT scan.  When we removed both shared and unshared uncertainty, the median brain 
dose was 32 mGy with zero SD (Figure 5a), where 500 brain doses for each scan are identical.  
The range of full cohort doses was from 47 mGy (min 20 mGy – max 67 mGy) as sampled from 
this distribution constructed from the 500 scan realizations.  When we introduced only unshared 
uncertainty, the mean of the median brain doses is 33 mGy with SD 0.028 mGy (Figure 5b).  The 
range of full cohort doses increased to 108 mGy (10 – 118 mGy).  With both shared and 
unshared uncertainties combined (Figure 5c), which is the same case with Figure 4a, the average 
of median doses is 35 mGy with SD 3 mGy with the dose spread of 577 mGy (1 – 578 mGy). 
Figure 6 shows changes in Pearson correlation coefficients as we group the scans by 
shared parameters: scan type and hospital.  The correlation coefficient for the full 1,000 scans 
without any grouping was 0.01.  By grouping them by scan types (brain, partial brain, and chest), 
we observe correlation coefficients increased to 0.02, 0.04, and 0.04, respectively.  By grouping 
1,000 scans by the three most frequent hospitals (Hospital 34, 61, and 57), the coefficients 
increase to 0.11, 0.12, and 0.19, respectively.  By grouping scans by brain scan and the three 
hospitals, the coefficients increase to 0.17, 0.23, and 0.23, respectively.  We confirmed that 
those shared parameters were actually shared in the sub groups as we intended in the sampling 
process of Figure 1. 
4 Discussion 
In our dose calculations for brain and chest scans shown in Figure 4, we observed about 1.3-fold 
greater COV in organ doses from chest scans compared to those from brain scans.  The key 
difference in parameter sampling between head and body scans is pitch: we used a fixed value 
of 1.0 for head scans but sampled from a triangular distribution for chest scans.  Uncertainties in 
scan start and length also have a different impact on dose in head and body scans.  The brain 
and active bone marrow (mainly distributed in cranium and mandible) are completely within the 
scan range in a head scan.  However, for chest scans, the thyroid and bottom of the lungs are 
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close to the scan start and end, respectively, which made those organ doses sensitive to the 
uncertainty in scan location. 
Based on the sensitivity analysis (Figure 5) for brain dose in brain scans, we deducted 
that the impact of shared uncertainty is much greater than that of unshared uncertainty.  The 
contribution of unshared uncertainty to the total COV is about 1%: 0.086% from unshared 
uncertainty in Figure 5b out of 8.528% from both shared and unshared uncertainty in Figure 5c.  
In terms of dose spread, adding unshared uncertainty increases the dose range by 2.3-fold: from 
47 mGy in Figure 5a to 108 mGy in Figure 5b.  Adding shared uncertainties to Figure 5b increase 
the dose range by 5.3-fold: from 108 mGy in Figure 5b to 577 mGy in Figure 5c.  Therefore, 
shared uncertainty has about twice greater impact on total dose spread than unshared 
uncertainty.  The results revealed that to increase the accuracy in brain dose in brain CT scans, it 
will be more efficient to focus on reducing uncertainty in shared parameters such as CTDIvol, 
tube potential, and pitch rather than unshared parameters.  However, we believe the 
contribution may differ for other scan types. 
We compared our revised organ doses with the previous data that were published in 
20126.  Table 3 shows the median, 2.5th, and 97.5th percentile of all 500 brain and active marrow 
doses in brain scans for the total scans in the cohort by three time-periods (<1990, 1990 - 1999, 
and >=2000) and age groups.  In the scans before 1990 and 1990-1999, age-averaged organ 
doses are shown but age-dependent organ doses are tabulated for the time period >=2000.  The 
organ doses we published previously6 are tabulated in Table 4, which shows the median, 2.5th, 
and 97.5th percentile of a single brain and active marrow doses for the total scans.  We found 
that the age-averaged brain median dose <1990 in the previous dosimetry was about 20% 
smaller than the values given in the current study.  This is because our previous CTDIvol values6 
based on the UK national surveys were smaller than the values in the current study obtained 
from CT film data.  The brain dose >=2000 in the previous dosimetry is up to 54% (age 10-14) 
greater than the dose in the current study because the continuous reduction of CTDIvol after 
1990 (Figure 3) observed from CT films was not accounted for in the previous dosimetry.  The 
active marrow doses in the previous dosimetry are comparable to those in the current study. 
There are a number of limitations in the current study.  First, the parameter probability 
distributions and regression model were derived from a small number of empirical data 
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representing less than 1% of the total scans in the cohort.  However, this is the only set of such 
scans that we are aware of as it is extremely time consuming to retrieve CT films from hospitals 
and manually extract scan parameters from the printed films especially for the time period 
before 2000 when electronic archiving systems were not yet implemented.  Some scan 
parameters such as pitch were not available on CT film or DICOM data, so it was necessary to 
use UK national surveys.  However, we attempted to include uncertainties in all scan parameters 
including pitch into the revised dose calculations, which we consider a strength of the current 
study.  Another limitation was that we did not account for tube current modulation technique 
(about 5% of scans among the CT film data).  Some organ doses in chest (e.g., lung) or 
abdominal scans might be over-estimated by simplifying tube current variations19.  However, it 
must be noted that the simplification may have less impact on head CT scans (about 60% of the 
scans in the UK CT cohort) compared with body scans and we are limiting our risk analysis to 
brain cancer and leukemia in brain scans because of limited number of other cancer cases3.  
Lastly, we used organ dose conversion coefficients derived from the computational human 
phantom series with reference body size because body size measurement was not available 
from the cohort data.  However, we plan to incorporate the uncertainty from the variation in 
body size in the future dosimetry revision by using the body size-dependent computational 
phantom library24. 
5 Conclusion 
Using parameter probability distributions and regression models derived from empirical data 
collected from the subset of participating hospitals in the UK CT cohort study, we have now 
incorporated uncertainties in CT parameters into our organ dose estimates.  This new set of 
dose estimates revises and augments the previous set of organ dose estimates in which no 
uncertainties were taken into account.  A total of 500 realizations of organ dose were calculated 
for each scan in the cohort using a Monte Carlo random sampling approach combined with 
NCICT organ dose calculator.  We learned from the sensitivity analysis that in case of brain dose 
in brain scan shared uncertainties have a major impact on the resulting dose uncertainty 
compared to unshared uncertainty.  We also found that the previous brain doses were slightly 
underestimated for <1990 and slightly overestimated for >1990 compared to the revised 
dosimetry results of the present study.  A risk analysis using the updated doses is underway to 
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evaluate the impact of dose uncertainties on the risk coefficients and their confidence intervals 
in the UK pediatric CT cohort.  The procedure we developed to quantify uncertainty from 
dosimetric parameters and propagate them into dose can be applied to other epidemiological 
studies of medical exposures. 
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Figure captions 
Figure 1. The workflow of the organ dose calculations by combining the Monte Carlo parameter 
sampling and NCICT organ dose calculator.  Shared and unshared uncertainties in different scan 
parameters are incorporated in the process. 
Figure 2. Probability distributions for tube potentials for (a) head and (b) body scans by two scan 
periods (before and after 1995). 
Figure 3. Temporal changes of CTDIvol for (a) brain and (b) chest scan at different age groups. 
Figure 4. The cumulative distribution functions (CDFs) of the 500 organ dose realizations for (a) 
brain and (b) active marrow in brain scan and (c) lung and (d) thyroid in chest scan.  Mean and 
standard deviation are included in each plot. 
Figure 5. The cumulative distribution functions (CDFs) of the 500 organ dose realizations for 
brain in brain scans (a) when both shared and unshared uncertainties are removed, (b) when 
only unshared uncertainties are included, and (c) when both shared and unshared uncertainties 
are included. 
Figure 6. Pearson correlation coefficients among the 500 sub-cohort members by grouping 
based on different shared parameters: scan type and hospital.
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Table 1. Number of scans for different scan types in the UK CT cohort. 
Scan type Number of scans Percent (%) 
Brain 174,144 54.76 
Abdomen 22,529 7.08 
Unknown 22,297 7.01 
Chest 21,796 6.85 
Partial brain 20,933 6.58 
Extremity 18,865 5.93 
Pelvis 12,573 3.96 
Spine 5,820 1.83 
Facial bones 5,363 1.69 
Neck 3,551 1.12 
High resolution CT 2,586 0.81 
C-spine 1,937 0.61 
L-spine 1,906 0.6 
Hip 1,647 0.52 
Whole body 1,310 0.41 
Shoulder 471 0.15 
T-spine 264 0.08 
Total 317,992 100.0 
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Table 2a. Parameters for multivariate normal distribution used in the regression model of CTDIw 
at 120 kVp.  These parameters are shared by all across 500 realizations but 𝜃 was only shared by 
those with the same scan types. 
Parameter Description Mean Standard Error 
𝐵0 (head) Intercept  3.500 0.060 
𝐵0 (body) Intercept 3.750 0.060 
𝐵1 Coefficient on age variable 0.023 0.004 
𝐵2 Coefficient on scan year variable -0.067 0.005 
𝜃 (head) Full head scans indicator (reference) 0.000 NA 
𝜃 (abdomen) Abdomen scans indicator -0.489 0.077 
𝜃 (pelvis) pelvis scans indicator -0.602 0.087 
𝜃 (chest) Chest scans indicator -0.807 0058 
𝜃 (extremity) Extremity scans indicator -1.073 0.091 
𝜃 (neck) Neck scans indicator -0.744 0.086 
𝜃 (partial head) Partial head scans indicator -0.396 0.061 
𝜃 (spine) Spine scans indicator -0.242 0.153 
 
Table 2b. Variations for hospitals, CT scan studies, and residual used in the regression model of 
CTDIw at 120 kVp.  All variations were shared across 500 realizations except residual variations. 
The normal deviates used to generate samples for these variables were constrained to the 98% 
confidence interval. 
Parameter Description Unshared Shared 
Distribution Mean SD Distribution Mean SD 
ℎ𝑣 Variation within a hospital - - - Normal 0.000 0.241 
𝑠𝑣 Variation within a study - - - Normal 0.000 0.359 
𝑟𝑣 Residual random variation. Normal 0.000 0.249 - - - 
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Table 3. Dose to the brain and active marrow for brain scans by three time-periods and age 
group, which was extracted from the 500 dose realizations simulated in the current study. 
Scan Year Age  
Brain dose (mGy) 
 
Active Marrow dose (mGy) 
 
Median 2.5th 97.5th 
 
Median 2.5th 97.5th 
<1990 Age-average 
 
52 15 173 
 
11 2 45 
1990-1999 Age-average 
 
38 11 132 
 
7 1 31 
>= 2000 
0-4 
 
24 7 80 
 
8 2 26 
5-9 
 
24 7 80 
 
6 2 21 
10-14 
 
26 8 87 
 
4 1 14 
>=15   29 9 98  2 1 8 
 
Table 4. Dose to the brain and active marrow in brain scans by three time periods, which was 
extracted from the previous cohort dose6 with no uncertainty included. 
Scan Year Age  
Brain dose (mGy) 
 
Active Marrow dose (mGy) 
 
Median 2.5th 97.5th 
 
Median 2.5th 97.5th 
<1990 Age-average 
 
41 32 56 
 
11 1 17 
1990-1999 Age-average 
 
41 32 56 
 
7 1 17 
>= 2000 
0-4 
 
28 23 56 
 
9 8 17 
5-9 
 
34 28 42 
 
8 7 13 
10-14 
 
40 35 42 
 
6 5 7 
>=15   38 32 44  2 1 6 
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